Authentication
Sign In
Facebook Connect
Create account
Dashboard
Providers
Publications
Networks
Clusters
Virtual Clinics
Directories
ask Dr Jenny
Cancer
Cosmetic Surgery
Dentistry
Diabetes
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Haematology
Healthcare
Health Policy
Heart disease
Hepatology
Medical Technology
Medicine
Nephrology
Neurosurgery
Obstetrics and Gynaecology
Ophthalmology
Orthopaedics
Paediatrics
Palliative Care
Patients' Voices
Plastic and Reconstructive Surgery
Pregnancy & childbirth
Preventive medicine
Pulmonology
Radiotherapy
Rheumatology
STD
Urology
Vascular Disease
Weight Management
Library
You must log in to use
this feature.
My Account
Create account
Sign In
Facebook Connect
Author
Mike Birrer
View provider
Details
Likes
11
Followers
19
Directory
Cancer
Tags
5 year survival
adverse events
Cancer
Chemotherapy
Clinical trials
Drug development
neoadjuvant therapy
Phase 3 trial
progression-free survival
recurrence
Sponsored
Given the nature of phase 3 clinical trials is it possible to stratify patients as is required for successful?
Play
Current Time
0:00
/
Duration Time
0:00
Remaining Time
-0:00
Loaded: 0%
Progress: 0%
00:00
Fullscreen
00:00
Mute
Subtitles
subtitles off
Captions
captions off
Chapters
Chapters
Comments
comments
Comments